Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:1287 (23 June), doi:10.1136/bmj.39247.716806.3A
| The first 150 words of the full text of this article appear below. |
Giles and Fitzmaurice did not discuss another use of estimated renal functionto guide changes in the dosage regimens of drugs that are eliminated unchanged by the kidneys, that have active metabolites that are eliminated by the kidneys, or whose pharmacodynamic effects are affected by renal insufficiency.1 This is particularly important for drugs that have a low therapeutic index.
Recommendations about drug dosage regimens given in manufacturers' summaries of product characteristics and in secondary sources, such as the British National Formulary, are based on creatinine clearance. It is therefore customary when altering dosage regimens in renal insufficiency to estimate glomerular filtration rate (GFR) by using calculated creatinine clearance, usually derived from the Cockcroft-Gault equation for adults2 or the Schwartz-Haycock equation for children.3
The eGFR estimated by the modified four variable modification of diet in renal disease (MDRD) equation underestimates true GFR more than the Cockcroft-Gault equation does in younger patients
Jeffrey K Aronson, reader in clinical pharmacology
Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford OX2 6HA
jeffrey.aronson@clinpharm.ox.ac.uk